These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 7530242

  • 1. Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis.
    Simpson IN, Finlay J, Winstanley DJ, Dewhurst N, Nelson JW, Butler SL, Govan JR.
    J Antimicrob Chemother; 1994 Sep; 34(3):353-61. PubMed ID: 7530242
    [Abstract] [Full Text] [Related]

  • 2. Isolation from clinical sources of Burkholderia cepacia possessing characteristics of Burkholderia gladioli.
    Baxter IA, Lambert PA, Simpson IN.
    J Antimicrob Chemother; 1997 Feb; 39(2):169-75. PubMed ID: 9069537
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients.
    Traczewski MM, Brown SD.
    Antimicrob Agents Chemother; 2006 Feb; 50(2):819-21. PubMed ID: 16436756
    [Abstract] [Full Text] [Related]

  • 4. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.
    Kiska DL, Kerr A, Jones MC, Caracciolo JA, Eskridge B, Jordan M, Miller S, Hughes D, King N, Gilligan PH.
    J Clin Microbiol; 1996 Apr; 34(4):886-91. PubMed ID: 8815102
    [Abstract] [Full Text] [Related]

  • 5. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.
    Vandamme P, Holmes B, Vancanneyt M, Coenye T, Hoste B, Coopman R, Revets H, Lauwers S, Gillis M, Kersters K, Govan JR.
    Int J Syst Bacteriol; 1997 Oct; 47(4):1188-200. PubMed ID: 9336927
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Microbiological and epidemiological features of clinical respiratory isolates of Burkholderia gladioli.
    Segonds C, Clavel-Batut P, Thouverez M, Grenet D, Le Coustumier A, Plésiat P, Chabanon G.
    J Clin Microbiol; 2009 May; 47(5):1510-6. PubMed ID: 19297595
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis.
    Saiman L, Chen Y, Gabriel PS, Knirsch C.
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1105-7. PubMed ID: 11897598
    [Abstract] [Full Text] [Related]

  • 12. Major Aspects of Burkholderia gladioli and Burkholderia cepacia Infections in Children.
    Bedir Demirdag T, Ozkaya Parlakay A, Aygar IS, Gulhan B, Kanik Yuksek S.
    Pediatr Infect Dis J; 2020 May; 39(5):374-378. PubMed ID: 32118858
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward.
    Döring G, Jansen S, Noll H, Grupp H, Frank F, Botzenhart K, Magdorf K, Wahn U.
    Pediatr Pulmonol; 1996 Feb; 21(2):90-100. PubMed ID: 8882212
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of three oligonucleotide primer sets in PCR for the identification of Burkholderia cepacia and their differentiation from Burkholderia gladioli.
    Clode FE, Kaufmann ME, Malnick H, Pitt TL.
    J Clin Pathol; 1999 Mar; 52(3):173-6. PubMed ID: 10450174
    [Abstract] [Full Text] [Related]

  • 16. Susceptibility of multiresistant strains of Burkholderia cepacia to honey.
    Cooper RA, Wigley P, Burton NF.
    Lett Appl Microbiol; 2000 Jul; 31(1):20-4. PubMed ID: 10886608
    [Abstract] [Full Text] [Related]

  • 17. Sodium nitrite-mediated killing of the major cystic fibrosis pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia under anaerobic planktonic and biofilm conditions.
    Major TA, Panmanee W, Mortensen JE, Gray LD, Hoglen N, Hassett DJ.
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4671-7. PubMed ID: 20696868
    [Abstract] [Full Text] [Related]

  • 18. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients.
    LiPuma JJ, Dulaney BJ, McMenamin JD, Whitby PW, Stull TL, Coenye T, Vandamme P.
    J Clin Microbiol; 1999 Oct; 37(10):3167-70. PubMed ID: 10488171
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard?
    Butler SL, Doherty CJ, Hughes JE, Nelson JW, Govan JR.
    J Clin Microbiol; 1995 Apr; 33(4):1001-4. PubMed ID: 7540623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.